{"id":43883,"date":"2021-09-08T09:01:46","date_gmt":"2021-09-08T07:01:46","guid":{"rendered":"https:\/\/www.aiom.it\/?p=43883"},"modified":"2021-09-08T09:01:46","modified_gmt":"2021-09-08T07:01:46","slug":"nivolumab-plus-ipilimumab-vs-nivolumab-for-previously-treated-patients-with-stage-iv-squamous-cell-lung-cancer-the-lung-map-s1400i-phase-3-randomized-clinical-trial","status":"publish","type":"post","link":"https:\/\/www.aiom.it\/en\/nivolumab-plus-ipilimumab-vs-nivolumab-for-previously-treated-patients-with-stage-iv-squamous-cell-lung-cancer-the-lung-map-s1400i-phase-3-randomized-clinical-trial\/","title":{"rendered":"Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial"},"content":{"rendered":"<p><em>Scott N Gettinger, Mary W Redman, Lyudmila Bazhenova, Fred R Hirsch, Philip C Mack, Lawrence H Schwartz, Jeffrey D Bradley, Thomas E Stinchcombe, Natasha B Leighl, Suresh S Ramalingam, Susan S Tavernier, Hui Yu, Joseph M Unger, Katherine Minichiello, Louise Highleyman, Vassiliki A Papadimitrakopoulou, Karen Kelly, David R Gandara, Roy S Herbst <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-34642\" src=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2019\/11\/JAMA-Oncology_cover-225x300.jpg\" alt=\"\" width=\"225\" height=\"300\" srcset=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2019\/11\/JAMA-Oncology_cover-225x300.jpg 225w, https:\/\/www.aiom.it\/wp-content\/uploads\/2019\/11\/JAMA-Oncology_cover.jpg 250w\" sizes=\"auto, (max-width: 225px) 100vw, 225px\" \/><\/em><\/p>\n<p><em>JAMA Oncology, 2021 Jul 15<\/em><\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34264316\/\">Abstract link<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Scott N Gettinger, Mary W Redman, Lyudmila Bazhenova, Fred R Hirsch, Philip C Mack, Lawrence H Schwartz, Jeffrey D Bradley, Thomas E Stinchcombe, Natasha B Leighl, Suresh S Ramalingam, Susan S Tavernier, Hui Yu, Joseph M Unger, Katherine Minichiello, Louise Highleyman, Vassiliki A Papadimitrakopoulou, Karen Kelly, David R Gandara, Roy S Herbst JAMA Oncology, 2021 [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":34645,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[255],"tags":[],"class_list":["post-43883","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articoli-scientifici-en"],"_links":{"self":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/43883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/comments?post=43883"}],"version-history":[{"count":2,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/43883\/revisions"}],"predecessor-version":[{"id":43885,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/43883\/revisions\/43885"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media\/34645"}],"wp:attachment":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media?parent=43883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/categories?post=43883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/tags?post=43883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}